HARVARD BIOSCIENCE INC (HBIO) Stock Overview
USA - NASDAQ:HBIO - US4169061052 - Common Stock
HBIO Key Statistics, Chart & Performance
The current stock price of HBIO is 0.4196 USD. In the past month the price decreased by -4.98%. In the past year, price decreased by -83.41%.
HBIO Latest News, Press Relases and Analysis
HBIO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 23.97 | 198.17B | ||
| DHR | DANAHER CORP | 26.89 | 144.97B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 134.42 | 43.85B | ||
| A | AGILENT TECHNOLOGIES INC | 25.07 | 38.73B | ||
| IQV | IQVIA HOLDINGS INC | 17.28 | 33.69B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 31.14 | 26.24B | ||
| WAT | WATERS CORP | 27.06 | 19.70B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 37.61 | 18.82B | ||
| TEM | TEMPUS AI INC | N/A | 16.75B | ||
| ILMN | ILLUMINA INC | 22.56 | 14.43B | ||
| ICLR | ICON PLC | 13.87 | 14.27B | ||
| MEDP | MEDPACE HOLDINGS INC | 37.27 | 14.08B |
Related stock screener links
About HBIO
Company Profile
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. The company is headquartered in Holliston, Massachusetts and currently employs 330 full-time employees. The company went IPO on 2013-10-21. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.
Company Info
HARVARD BIOSCIENCE INC
84 October Hill Rd
Holliston MASSACHUSETTS 01746 US
CEO: James Green
Employees: 343
Phone: 15088938999
HARVARD BIOSCIENCE INC / HBIO FAQ
What is the stock price of HARVARD BIOSCIENCE INC today?
The current stock price of HBIO is 0.4196 USD. The price decreased by -5.05% in the last trading session.
What is the ticker symbol for HARVARD BIOSCIENCE INC stock?
The exchange symbol of HARVARD BIOSCIENCE INC is HBIO and it is listed on the Nasdaq exchange.
On which exchange is HBIO stock listed?
HBIO stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for HARVARD BIOSCIENCE INC stock?
8 analysts have analysed HBIO and the average price target is 2.04 USD. This implies a price increase of 386.18% is expected in the next year compared to the current price of 0.4196. Check the HARVARD BIOSCIENCE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is HARVARD BIOSCIENCE INC worth?
HARVARD BIOSCIENCE INC (HBIO) has a market capitalization of 18.68M USD. This makes HBIO a Nano Cap stock.
How many employees does HARVARD BIOSCIENCE INC have?
HARVARD BIOSCIENCE INC (HBIO) currently has 343 employees.
What are the support and resistance levels for HARVARD BIOSCIENCE INC (HBIO) stock?
HARVARD BIOSCIENCE INC (HBIO) has a resistance level at 0.44. Check the full technical report for a detailed analysis of HBIO support and resistance levels.
Is HARVARD BIOSCIENCE INC (HBIO) expected to grow?
The Revenue of HARVARD BIOSCIENCE INC (HBIO) is expected to decline by -8.8% in the next year. Check the estimates tab for more information on the HBIO EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy HARVARD BIOSCIENCE INC (HBIO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of HBIO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of HBIO, evaluating the profitability, health, valuation and growth aspects
- HARVARD BIOSCIENCE INC (HBIO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- HARVARD BIOSCIENCE INC (HBIO) Sales and EPS estimates to see what analysts future expectations are.
- HARVARD BIOSCIENCE INC (HBIO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- HARVARD BIOSCIENCE INC (HBIO) Insider and Institutional Ownership to learn about the owners and their transactions.
- HARVARD BIOSCIENCE INC (HBIO) Stock Chart to make your own analysis
- HARVARD BIOSCIENCE INC (HBIO) Latest news and press-releases to stay up to date.
Does HARVARD BIOSCIENCE INC (HBIO) stock pay dividends?
HBIO does not pay a dividend.
When does HARVARD BIOSCIENCE INC (HBIO) report earnings?
HARVARD BIOSCIENCE INC (HBIO) will report earnings on 2025-11-05, before the market open.
What is the Price/Earnings (PE) ratio of HARVARD BIOSCIENCE INC (HBIO)?
The PE ratio for HARVARD BIOSCIENCE INC (HBIO) is 20.98. This is based on the reported non-GAAP earnings per share of 0.02 and the current share price of 0.4196 USD. Check the full fundamental report for a full analysis of the valuation metrics for HBIO.
What is the Short Interest ratio of HARVARD BIOSCIENCE INC (HBIO) stock?
The outstanding short interest for HARVARD BIOSCIENCE INC (HBIO) is 1.64% of its float. Check the ownership tab for more information on the HBIO short interest.
HBIO Technical Analysis
HBIO Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to HBIO. Both the profitability and financial health of HBIO have multiple concerns.
HBIO Financial Highlights
Over the last trailing twelve months HBIO reported a non-GAAP Earnings per Share(EPS) of 0.02. The EPS decreased by -71.43% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -71.67% | ||
| ROE | -364.88% | ||
| Debt/Equity | 0 |
HBIO Forecast & Estimates
8 analysts have analysed HBIO and the average price target is 2.04 USD. This implies a price increase of 386.18% is expected in the next year compared to the current price of 0.4196.
For the next year, analysts expect an EPS growth of -57.5% and a revenue growth -8.8% for HBIO